Clinical AI for Patient Deterioration Prediction
Client profile: Regional health network
14 hospitals, alert fatigue from rule-based early warning scores, late deterioration detection. We built a validated deterioration prediction model, cut false positives 62 percent, detected events 4.7 hours earlier.
Headline metrics
- False positive reduction
- 62%
- Earlier detection
- 4.7 hrs
- Hospitals deployed
- 14
- Equity gap closed
- Yes
Summary
Challenge
A regional health network running 14 hospitals wanted to reduce in-hospital mortality from late detection of clinical deterioration. Existing rule-based early warning scores produced high false-positive rates, leading to alert fatigue among nursing staff.
Approach
Magnis AI delivered a patient deterioration prediction model with HIPAA-aligned data flows, validated against 18 months of retrospective data and prospectively across two pilot sites. Model integrated into the existing EHR with single-screen alerting, designed for clinician acceptance, with equity audits across demographic groups.
Outcome
False positive rate reduced by 62 percent versus the prior early warning score. Detection of deterioration moved on average 4.7 hours earlier. Prospective study showed reduction in unplanned ICU transfers. Model now governed under the network's clinical AI committee with quarterly performance review.
Engagement narrative
Clinical context
The network's existing early warning score was rule-based (vital signs above or below thresholds). It produced high alert volumes (60+ per ward per shift) with low positive predictive value, leading to alert fatigue. Late detection of deterioration was a documented contributor to unplanned ICU transfers and a small but meaningful share of preventable in-hospital mortality.
Scoping and validation design (weeks 1 to 6)
Clinical leadership defined the use case: predict clinical deterioration up to 24 hours in advance with a specific positive predictive value target. SaMD assessment: confirmed non-device given the clinician-in-the-loop alerting design. Validation plan agreed before model build: 18 months retrospective on three sites, then 90-day prospective pilot on two sites, with equity audits across age, sex, ethnicity, and admission acuity.
Model development (weeks 7 to 18)
Features engineered from vital signs, lab results, medication administration, and nursing assessment data. Gradient-boosted ensemble compared against a deep learning baseline. Final model selected for performance and interpretability. SHAP explanations attached to every alert for clinician trust. HIPAA-aligned data flows: training and inference inside the network's secure environment, no PHI shared with external systems.
Pilot phase (weeks 19 to 30)
Prospective pilot on two sites. Single-screen alerting embedded in the existing EHR with three pieces of information: deterioration risk score, top three contributing factors (from SHAP), and suggested clinical actions. Nursing acceptance designed into the workflow. False positive rate cut by 62 percent vs the prior score. Median detection moved 4.7 hours earlier.
Rollout across 14 hospitals
Phased rollout over 16 weeks. Site-specific training, equity-audit refresh at each new site, change-control process for model updates established under the clinical AI committee. Quarterly performance review by the committee with real-world performance monitoring, drift detection, and incident reporting.
Client testimonial
“Our nurses trusted the model from week two because the explanations were clinically meaningful and the false positive rate was actually lower than what they were used to. That trust is what made the rollout across 14 hospitals possible.”
Chief Medical Information Officer, regional health network